Headlines

Moderna Inc. (MRNA) Q4 2025 (USD): EPS -2.11 (exp. -2.54), Revenue 700mln (exp. 635mln)

Newsquawk Staff ·

Moderna Inc. (MRNA) Q4 2025 (USD): EPS -2.11 (exp. -2.54), Revenue 700mln (exp. 635mln)

What it means

Moderna's Q4 2025 results beat expectations on both EPS and revenue, which indicates a stronger operational performance than analysts anticipated. This positive surprise could imply a more favorable outlook for the company's future growth, enhancing investor sentiment and potentially lifting share prices in the biotechnology sector.

Related headlines